Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung disease
Pharma
Boehringer breaks IPF treatment drought with new FDA approval
Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade.
Zoey Becker
Oct 8, 2025 8:56am
United shares surge on Tyvaso win in new lung disease population
Sep 2, 2025 3:34pm
Insmed's Brinsupri nabs landmark FDA nod in chronic lung disease
Aug 12, 2025 12:05pm
Boehringer backs drive to improve bronchiectasis management
Jul 2, 2025 9:23am
Respiratory patient groups decry pricing, access to lung meds
Jul 24, 2023 7:34am
Sanofi and Regeneron enlist Broadway actor for lung health med
Oct 26, 2022 7:45am
